EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of Vaccination in the Prevention of ECOPD

Filippo Sartori, Ernesto Crisafulli iD, Marcial Cariqueo, Claudia Di Chiara, Giulia Sartori, Alberto Fantin, Antoni Torres

Seminars in Respiratory and Critical Care Medicine · 01.06.2026 · 47 (03) · 323-333

DOI: 10.1055/a-2837-8778 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.06.2026. Verfasst von Filippo Sartori und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Vaccination, Respiratory Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 133 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exacerbations of chronic obstructive pulmonary disease (ECOPD) represent key events in the natural history of COPD and are associated with several adverse outcomes. Respiratory infections are major and potentially modifiable triggers of ECOPD, with viral pathogens such as the influenza virus, respiratory syncytial virus (RSV), and SARS-CoV-2, as well as bacterial infections caused by Streptococcus pneumoniae, playing a central role. This narrative review examines the current evidence supporting vaccination as a preventive strategy for ECOPD and discusses its translation into clinical practice. The biological rationale for vaccination in COPD is reviewed, including disease-related immune dysregulation, impaired mucociliary clearance, and increased susceptibility to respiratory pathogens. Evidence from randomized clinical trials, observational studies, meta-analyses, and real-world data is summarized for pneumococcal, influenza, SARS-CoV-2, and RSV vaccines. Pneumococcal vaccination has been shown to reduce the burden of community-acquired pneumonia and invasive pneumococcal disease, with conjugate and higher-valent vaccines providing enhanced immunogenicity in older and high-risk adults. Influenza vaccination consistently reduces severe exacerbations, hospitalizations, and mortality, with additional cardioprotective effects of relevance in COPD. SARS-CoV-2 vaccination markedly lowers the risk of severe COVID-19 and related respiratory deterioration in COPD, while recently licensed RSV vaccines offer a novel opportunity to prevent RSV-associated lower respiratory tract disease and potentially reduce exacerbation risk. Patient populations most likely to benefit from vaccination include frequent exacerbators, older adults, individuals with severe airflow limitation, multimorbidity, immune dysfunction, infection-prone phenotypes, and socially vulnerable groups. Future perspectives include precision vaccination strategies, novel vaccine platforms, coadministration approaches, and interventions to improve vaccine uptake. Vaccination emerges as a cornerstone of ECOPD prevention, with substantial potential to reduce exacerbation burden and improve long-term outcomes in COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveVaccinationRespiratory Tract InfectionsHumansPneumococcal VaccinesCOVID-19 VaccinesInfluenza VaccinesRespiratory Syncytial Virus VaccinesCOVID-19Influenza, HumanDisease Progression

Substanzen

Pneumococcal VaccinesCOVID-19 VaccinesInfluenza VaccinesRespiratory Syncytial Virus Vaccines

Autor:innen und Institutionen

  • Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Pneumology Department, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CI…
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
  • Department of Pulmonology, S. Maria della Misericordia University Hospital, Udine, Italy.

ORCID-Profile: Ernesto Crisafulli

Zitieren

APA

Sartori, F., Crisafulli, E., Cariqueo, M., Di Chiara, C., Sartori, G., Fantin, A., & Torres, A. (2026). Role of Vaccination in the Prevention of ECOPD. Seminars in Respiratory and Critical Care Medicine, 47(03), 323-333. https://doi.org/10.1055/a-2837-8778

Vancouver

Sartori F, Crisafulli E, Cariqueo M, Di Chiara C, Sartori G, Fantin A, et al. Role of Vaccination in the Prevention of ECOPD. Seminars in Respiratory and Critical Care Medicine. 2026;47(03):323-333. doi:10.1055/a-2837-8778

BibTeX
@article{Sartori2026,
  author = {Sartori, Filippo and Crisafulli, Ernesto and Cariqueo, Marcial and Di Chiara, Claudia and Sartori, Giulia and Fantin, Alberto and Torres, Antoni},
  title = {Role of Vaccination in the Prevention of ECOPD},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2026},
  volume = {47},
  number = {03},
  pages = {323--333},
  doi = {10.1055/a-2837-8778}
}
Kostenlos starten →